Shankar Biswas, Yashasvi Srivastava, Ayman Hamadttu. "Comparative effectiveness of first-line ribociclib plus aromatase inhibitor versus palbociclib plus aromatase inhibitor in HR+/HER2− metastatic breast cancer: A global real-world evidence study.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.19_suppl.45